We are live on ! Find out more
PPBT

Purple Biotech

10 hedge funds and large institutions have $224K invested in Purple Biotech in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,020% more call options, than puts

Call options by funds: $412K | Put options by funds: $10K

0% less ownership

Funds ownership: 0%0% (-0%)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

17% less funds holding

Funds holding: 1210 (-2)

28% less capital invested

Capital invested by funds: $311K → $224K (-$87.2K)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
10
Holders Change
-2
Holders Change %
-16.67%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
2
Closed
3
Calls
$412K
Puts
$10K
Net Calls
+$402K
Net Calls Change
+$214K

PPBT Hedge Fund Activity: Q3 2022 in Review

10 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Purple Biotech (PPBT) for Q3 2022, worth a combined $224K — down 28% from $311K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PPBT and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.

The largest buyer was Wealth Advisors of Iowa, opening a new position worth an estimated $26.6K. The largest seller was Virtu Financial, exiting entirely with an estimated $33K sold.

  • 10 institutional investors held Purple Biotech (PPBT) as of Q3 2022, down from 12 in Q2 2022.
  • Funds reported $224K of Purple Biotech stock for Q3 2022, down 28% quarter-over-quarter.
  • 1 fund opened new Purple Biotech positions in Q3 2022 and 3 closed out, a net change of -2 holders.
  • The largest Purple Biotech buyer in Q3 2022 was Wealth Advisors of Iowa, an estimated $26.6K added.
  • The largest Purple Biotech seller in Q3 2022 was Virtu Financial, an estimated $33K sold.

Based on aggregated 13F filings for Q3 2022.